Skip to main content

Xenetic Biosciences

Framingham, United States

Xenetic Biosciences is a biopharmaceutical company that provides drugs, cancer therapies, and vaccines.

$4.5M raised
Oct 2025
Post-IPO Equity

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Xenetic Biosciences

How much funding has Xenetic Biosciences raised?
Xenetic Biosciences has raised $4.5M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in October 2025.
Who are Xenetic Biosciences's investors?
Xenetic Biosciences's investors include Baxter International.
Where is Xenetic Biosciences headquartered?
Xenetic Biosciences is headquartered in Framingham, United States.
What does Xenetic Biosciences do?
Xenetic Biosciences is a biopharmaceutical company that provides drugs, cancer therapies, and vaccines.
What stage is Xenetic Biosciences at?
Xenetic Biosciences is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Xenetic Biosciences — Funding & Investors." VCBacked, October 10, 2025, https://www.vcbacked.co/company/xenetic-biosciences. Accessed July 2, 2026.
APA
VCBacked. (2025). Xenetic Biosciences — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/xenetic-biosciences
Wikipedia (cite web)
{{cite web |title=Xenetic Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/xenetic-biosciences |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .